Soros buys Arthur J. Gallagher, boosts Accenture in Q4
George Soros’ Soros Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund’s new buys during the fourth ...
Starboard Value buys Pfizer, exits Humana in Q4
Jeffrey Smith’s Starboard Value disclosed in an SEC filing its holdings as of December 31, 2024. The fund’s new buys during the fourth quarter ...
FDA approves new ADCETRIS regimen for lymphoma treatment
NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with $63.6 billion in annual revenue and an impressive 74% gross profit margin, has announced the U.S. Food and Drug Administration's ...
Pfizer: 3 Key Risks That Warrant A Sell
Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...
Jefferies raises Pfizer stock price target to $34, maintains Buy
Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while ...
https//insights.som.yale.edu4d
What Investors Are Missing about Pfizer and Merck
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...